Endothelial dysfunction: A unifying hypothesis for the burden of cardiovascular diseases in sub-Saharan Africa

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S56-S60

  Sampson, Uchechukwu K A ^a   Engelgau, Michael ^a   Peprah, Emmanuel K ^a   Mensah, George A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiovascular disease; Endothelium; Outcomes; Public health; Risk factors

Indexed keywords

TOBACCO SMOKE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

AFRICA SOUTH OF THE SAHARA; AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; FRUIT; HOUSING; HUMAN; INCOME; INFLAMMATION; PHYSICAL ACTIVITY; PUBLIC HEALTH SERVICE; SOCIAL DETERMINANTS OF HEALTH; THROMBOSIS; TOBACCO USE; URBANIZATION; VASCULAR ENDOTHELIUM; VASCULAR REMODELING; VEGETABLE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; ENDOTHELIUM; HEALTH; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR;

AFRICA SOUTH OF THE SAHARA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; ENDOTHELIUM; GLOBAL HEALTH; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; RISK FACTORS;

EID: 84930017860     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2015-043     Document Type: Article

References (33)

1. Capewell S and O'Flaherty M. What explains declining coronary mortality? Lessons and warnings. Heart 2008; 94: 1105-1108.
2. Marsh B. Declining lethality. The New York Times. January 4, 2014.
3. Libby P and Ridker PM. Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006; 48: A33-46.
4. Jahangir E, Fazio S, Sampson UK. Incident diabetes and statins: the blemish of an undisputed heavy weight champion? Br J Clin Pharmacol 2013; 75: 955-958.
5. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 385(9963): 117-171.
6. Mensah GA, Catravas JD, Engelgau MM, Hooper WC, Madeddu P, Ryan US, et al. Vascular endothelium summary statement VI: Research directions for the 21st century. Vasc Pharmacol 2007; 46: 330-332.
7. Mensah GA. Healthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease prevention. Vasc Pharmacol 2007; 46: 310-314.
8. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285-1295.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
10. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-1474.
11. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109: 1981-1986.
12. Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS, et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004; 24: 739-743.
13. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
14. Gokce N, Keaney JF, Jr., Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41: 1769-1775.
15. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006; 10: 318-332.
16. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-798.
17. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004; 110: 2918-2923.
18. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-686.
19. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%. Br Med J 2004; 329: 1447-1450.
20. Franzoni F, Ghiadoni L, Galetta F, Plantinga Y, Lubrano V, Huang Y, et al. Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005; 18: 510-516.
21. Fuchsjager-Mayrl G, Pleiner J, Wiesinger GF, Sieder AE, Quittan M, Nuhr MJ, et al. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 2002; 25: 1795-1801.
22. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003; 26: 2119-2125.
23. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 2001; 20: 97-105.
24. Wildman RP, Schott LL, Brockwell S, Kuller LH, Sutton-Tyrrell K. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol 2004; 44: 579-585.
25. Hwa C, Sebastian A, Aird WC. Endothelial biomedicine: its status as an interdisciplinary field, its progress as a basic science, and its translational bench-to-bedside gap. Endothelium: J Endothelial Cell Res 2005; 12: 139-151.
26. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al., and investigators P. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014; 371: 818-827.
27. Krumholz HM, Curry LA, Bradley EH. Survival after acute myocardial infarction (SAMI) study: the design and implementation of a positive deviance study. Am Heart J 2011; 162: 981-987 e9.
28. Bradley EH, Curry LA, Ramanadhan S, Rowe L, Nembhard IM, Krumholz HM. Research in action: using positive deviance to improve quality of health care. Implement Sci 2009; 4: 25.
29. Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367: 1310-1320.
30. Brotman DJ, Walker E, Lauer MS, O'Brien RG. In search of fewer independent risk factors. Arch Intern Med 2005; 165: 138-145.
31. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380: 572-580.
32. Investigators A-H, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011; 365: 2255-2267.
33. Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Khalyfa AA, Wang Y, et al. Genetic variance in nitric oxide synthase and endothelin genes among children with and without endothelial dysfunction. J Translational Med 2013; 11: 227.